RT info:eu-repo/semantics/article
T1 Impact of different nebulisation systems on patient comfort in bronchiolitis: a randomised controlled cross-over trial
A1 Valencia Ramos, Juan
A1 Ochoa Sangrador, Carlos
A1 García, María
A1 Oyagüez, Pablo
A1 Arnaez, Juan
K1 Bronchiolitis
K1 Comfort
K1 COMFORT-Behavior scale
K1 Family-centered care
K1 Pediatric Critical Care
K1 Bronquiolitis
K1 Enfermedades infecciosas en niños
K1 Communicable diseases in children
AB Objective: To test the hypothesis that greater comfort is achieved using a nebuliser integrated into a high-flow nasal cannula (nebulisation system integrated in high-flow nasal cannula (NHF)) than using a jet nebuliser (JN), and to explore differences in analgesia requirement and the possibility of feeding during nebulisation.Design: Randomised cross-over trial.Setting: Paediatric intensive care unit.Patients: Children aged <24 months diagnosed with bronchiolitis between November 2016 and May 2017.Interventions: Nebulisations using NHF and JN.Main outcome measures: COMFORT–Behaviour Scale (CBS) and Numerical Rating Comfort Scale (NRSc) were used to measure comfort, and Numerical Rating Satisfaction Scale (NRSs) was used to assess satisfaction before, during and after nebulisation. Other variables included feeding, analgesia, need for being held and respiratory and heart rates.Results: Thirty-three children with 233 nebulisations were included in the study. The median age was 3.0 (IQR 2–9) months. Comfort and satisfaction were greater with NHF than with JN. The median staff-recorded CBS, NRSc and NRSs scores for NHF versus JN were 13 (IQR 9–15) vs 17 (IQR 13–23), 8 (IQR 7–0) vs 7 (IQR 4–8), and 4 (IQR 3–4) vs 2 (IQR 2–3), respectively; and caregiver-recorded scores were 12 (IQR 10–15) vs 19 (IQR 13–24), 9 (IQR 7–10) vs 4 (IQR 1–6), and 4 (IQR 3–4) vs 2 (IQR 1–3), respectively (p<0.001). Children who received NHF had lower cardiac and respiratory rates, needed to be held less often during therapy and required less analgesia (p<0.001).Conclusion: Nebulisation through NHF appears to be a better alternative to JN in terms of comfort and satisfaction as well as making feeding possible during nebulisation.
PB BMJ Publishing Group
SN 0003-9888
YR 2022
FD 2022-12
LK http://hdl.handle.net/10259/10046
UL http://hdl.handle.net/10259/10046
LA eng
NO This study was supported by Fundación Ernesto Sánchez Villares (FESV) (01/2017), and Aerogen (Philips) provided nebulisers free of charge. The opinions, results and conclusions reported in this paper are those of the authors and are independent of funding sources. No endorsement by FESV is intended or inferred.
DS Repositorio Institucional de la Universidad de Burgos
RD 03-mar-2025